Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/22/1993 | EP0412125B1 Pharmaceutical dosage form for the medication of fish |
09/22/1993 | EP0258356B1 New pharmaceutical compositions for inhalation |
09/22/1993 | CN1076338A Method for producing health care chewing gum |
09/21/1993 | US5246997 Method of making a hot-melt silicone pressure sensitive adhesive-coated substrate |
09/21/1993 | US5246949 Preparation for endermism containing dopamine derivatives |
09/21/1993 | US5246714 Time-release beads with polypropylene or polyethylene core; |
09/21/1993 | US5246711 Dosage form for treating dysthymia |
09/21/1993 | US5246710 Dosage form for treating cyclothymia |
09/21/1993 | US5246709 Antiemetic therapy |
09/21/1993 | US5246707 Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes |
09/21/1993 | US5246706 Laminated elastomer patch |
09/21/1993 | US5246705 Thermoplastic or crosslinked elastomer |
09/21/1993 | US5246704 Vaginal suppository |
09/21/1993 | US5246702 Process for the purification of commercial carrageenins |
09/21/1993 | US5246697 Kanamycin A with vehicle or support |
09/21/1993 | US5245896 Quick-change tool holder with center height adjustment mechanism |
09/21/1993 | CA1322331C Galenical formulations |
09/21/1993 | CA1322330C Nasal solutions comprising human calcitonin |
09/21/1993 | CA1322329C Somatotropin prolonged release |
09/21/1993 | CA1322328C Stabilized compositions containing epidermal growth factor |
09/19/1993 | WO1993018764A2 VERAPAMIL HCl FORMULATION AND OTHER OPHTHALMIC SOLUTIONS WITH BUFFER SYSTEM FOR OCULAR ADMINISTRATION |
09/19/1993 | CA2102110A1 Verapamil hci formulation and other ophthalmic solutions with buffer system for ocular administration |
09/18/1993 | WO1993018757A1 Method of producing porous delivery devices |
09/18/1993 | CA2091713A1 Dosage aerosols containing the active substance flezelastin and related structures |
09/17/1993 | CA2091641A1 Spun matrix materials containing oleaginous materials in edible protein compositions |
09/17/1993 | CA2091550A1 New derivatives of physostigmine, their use and pharmaceutical formulations containing them |
09/16/1993 | WO1993018036A1 Condensed indole derivatives as 5ht4-receptor antagonists |
09/16/1993 | WO1993017784A1 Polysaccharide wall microcapsules containing primary alcohol functions and compositions containig same |
09/16/1993 | WO1993017716A1 Compositions for controlled delivery of pharmaceutical compounds |
09/16/1993 | WO1993017713A1 Pharmaceutical composition having site-specific delivery |
09/16/1993 | WO1993017704A1 Biodegradable bursting release system |
09/16/1993 | WO1993017687A1 Topical compositions containing steroids |
09/16/1993 | WO1993017679A1 Compositions containing ranitidine/bismuth carboxylates salts |
09/16/1993 | WO1993017675A1 Use of alkylureas and hydroxyurea as contraceptive agents |
09/16/1993 | WO1993017674A1 Topical use of local anaesthetic agents for rheumatoid arthritis as well as a pharmaceutical preparation and a method for the treatment thereof |
09/16/1993 | WO1993017669A1 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
09/16/1993 | WO1993017668A1 Controlled release acth containing microspheres |
09/16/1993 | WO1993017667A1 Composition for oral preparations |
09/16/1993 | WO1993017666A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
09/16/1993 | WO1993017665A1 Methods and apparatus for drug delivery using supercritical solutions |
09/16/1993 | WO1993017664A1 Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions |
09/16/1993 | WO1993017663A1 Pharmaceutical inhalation compositions |
09/16/1993 | WO1993017662A1 Improved implants |
09/16/1993 | WO1993017655A1 Topical aromatic releasing compositions |
09/16/1993 | WO1993017633A1 Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like |
09/16/1993 | CA2131990A1 Pharmaceutical composition having site-specific delivery |
09/16/1993 | CA2131832A1 Compositions for controlled delivery of pharmaceutical compounds |
09/16/1993 | CA2131530A1 Polysaccharide wall microcapsules containing primary alcohol functions and compositions containing same |
09/16/1993 | CA2131458A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
09/16/1993 | CA2129514A1 Controlled released acth containing microspheres |
09/15/1993 | EP0560329A1 Pranoprofen-containing, suspending medicinal composition |
09/15/1993 | EP0560207A1 Composition based on ibuprofen, for oral usage |
09/15/1993 | EP0560138A1 Drug formulations by liposomes and the process for their manufacture |
09/15/1993 | EP0560092A1 Tablets, granulates and pellets with a high drug content for highly concentrated solid administration forms |
09/15/1993 | EP0560014A1 Biodegradable film dressing and method for its formation |
09/15/1993 | EP0559897A1 Quick release coated preparation |
09/15/1993 | EP0559856A1 Antimicrobial preservation of platelets and blood factors |
09/15/1993 | EP0559827A1 High amylose starch substituted gelatin capsules. |
09/15/1993 | EP0559825A1 Method and device for treating tobacco addiction. |
09/15/1993 | EP0559812A1 Composition containing antihistamine h 2? receptor antagonists and bioadhesive material |
09/15/1993 | EP0559702A1 Retarded-action urapidil formulation. |
09/15/1993 | EP0559698A1 Methods of immobilizing liposomes in gel beads and similar materials, gel beads and similar materials with immobilized liposomes prepared by such methods and uses thereof |
09/15/1993 | EP0559645A1 Composition for solid pharmaceutical preparations containing active vitamins d 3? and process for preparation thereof |
09/15/1993 | EP0544671A4 Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting ph-dependent swelling |
09/15/1993 | EP0528998A4 Periodontal tissue regeneration barrier and method |
09/15/1993 | EP0490991B1 Dosage form for administering oral hypoglycemic glipizide |
09/15/1993 | EP0458950B1 Stabilization of k2p pro |
09/15/1993 | EP0457916B1 Plasma-irradiated solid preparation |
09/15/1993 | EP0457837A4 Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle |
09/15/1993 | EP0442949B1 Adhesive drug delivery composition |
09/15/1993 | EP0387300B1 Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained |
09/15/1993 | CN1076112A Change of lentinan powder to liquid for intravenous injection |
09/15/1993 | CN1076110A Patches for percutaneous administration of skin-whitening materials |
09/15/1993 | CN1076109A Prescription and productive process for "Xiao Kuining" tablets for curing ulcer |
09/15/1993 | CN1076078A Polymeric particles for dental applications |
09/14/1993 | US5244925 Emulsion for parenteral administration |
09/14/1993 | US5244924 Diluent for perfluorocarbons employed for retinal unfolding (unfolding pfcl) and method of treatment |
09/14/1993 | US5244881 Compositions based on imipyramine |
09/14/1993 | US5244678 Bupivacaine |
09/14/1993 | US5244677 Application system for drug containing microemulsions |
09/14/1993 | US5244673 Antiexudation, antiphlogistic and antimicrobial effect; aqueous or ointment base with protease inhibitor comprising elastatinal optionally mixed with aprotinin and/or soybean trypsin inhibitors |
09/14/1993 | US5244672 Composition containing liposomes stabilized by a stabilizing support based on atelocollagen and glycosaminoglycans |
09/14/1993 | US5244670 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress |
09/14/1993 | US5244669 Multilayer coating |
09/14/1993 | US5244668 Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
09/14/1993 | US5244663 Therapeutic method against allergy |
09/14/1993 | US5244652 Viscous surface active composition |
09/14/1993 | CA1322172C Antiviral pharmaceutical compositions containing cyclodextrin |
09/14/1993 | CA1322171C Liposome composition and its production |
09/14/1993 | CA1322170C Use of ethylene oxide/propylene oxide block copolymers for controlling foam in liquid pharmaceutical formulations, pharmaceutical formulations, and a process for their preparation |
09/14/1993 | CA1322166C Process for the preparation of collagen and obtained product |
09/14/1993 | CA1322159C Animal growth promotant |
09/14/1993 | CA1322133C Process for producing microcapsules |
09/13/1993 | CA2091552A1 Biodegradable film dressing and method for its formation |
09/13/1993 | CA2062924A1 Stable emulsions of perfluoropolyethers and fat substances and process for preparing them |
09/11/1993 | CA2091399A1 Pranoprofen-containing, suspending medicinal composition |
09/11/1993 | CA2091113A1 Liposomal active compound formulations and process for their production |
09/10/1993 | CA2091195A1 Poultry color-coded inactivated vaccines |
09/09/1993 | DE4206857A1 Absorbent compsn. contg. water soluble or swellable polysaccharide deriv. - includes small amt. of water swellable synthetic polymer, soft matrix, crosslinker, reactive additive and antiblocking agent, prepn., useful in packaging, hygiene prods., etc. |
09/09/1993 | DE4206856A1 Absorbent compsn. used in packaging and hygiene prods. - contains water soluble or swellable polysaccharide deriv., small amt. of water swellable synthetic polymer, soft matrix, crosslinker and antiblocking agent |